CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

CytoSorbents Announces Reverse Stock Split

Neutral
AI Analysis

Summary

CytoSorbents announced a reverse stock split previously approved by shareholders, intended to maintain compliance with Nasdaq's $1.00 minimum bid price requirement. The split is expected to become effective and begin trading on a split-adjusted basis on September 8, 2026.

Importance:2/10
Sentiment:
0.00
reverse_stock_splitnasdaq_compliancecorporate_action
Related Companies

Read the original article

Published by PR Newswire Biotech on September 3, 2026 11:00 AM

Read Original